ReviewJournal of clinical medicine2021

The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies.

Andres Garcia-Sampedro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.